For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

A large longitudinal study found that pesticide exposure and caffeinated soda intake were linked to more severe motor ...

Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion therapy, a cutting-edge ...

I do not want someone to develop an incurable neurodegenerative disease just so that I can have my grapes or wheat or ...

Known as much for their innovative videos and for their hits such as “Take on Me”, “Cry Wolf”, the band’s frontman shared ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

The University of California, San Francisco (UCSF) has received a $5 million donation from the Jean Pierre “JP” Conte Family ...

Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational ...

Roche and Prothena are forging ahead to late-stage studies for their investigational Parkinson’s disease antibody ...

Roche to advance prasinezumab into phase III development for early-stage Parkinson's disease: Basel Tuesday, June 17, 2025, 09:00 Hrs [IST] Roche announced its decision to proceed ...

Edwin Rivera is the co-founder and CEO of New York Fitness and Boxing in East Northport, which offers programs specifically ...

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage ...